The SMART trial raised questions about balloon-expandable valves in small aortic annuli; these new data offer some answers.
It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.
The study was stopped early to allow all patients with advanced PAH the option for treatment with the activin signaling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback